CDEK
← All organizations

Somerset Pharmaceuticals

For profitContributed to NME

Also known as: SOMERSET | SOMERSET THERAPS LLC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Mar 1, 2001

First marketed drug

Jun 5, 1989

First NDA

Jun 5, 1989

Last known activity

Jul 1, 2007

Acquired by Mylan on Jul 29, 2008

Timeline

1980s

  1. Jan 1, 1986

    Somerset Pharmaceuticals— Founded

  2. Jun 5, 1989

    selegiline— NDA Organization

2000s

  1. Jul 29, 2008

    Mylan— Acquired By

2020s

  1. Aug 9, 2024

    proparacaine— Marketing Organization

Drugs by trial phase (1 distinct, 5 trials)

Phase 4 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (65)

Recent trials (7)

Details

Founded
Tampa, FL, US Jan 1, 1986
First NDA
Jun 5, 1989
Last known activity
Jul 1, 2007

Designations held

  • Orphan drug
  • Priority review